Evidence map›Paper›PMID 34698407›Full record

ArticleJournal of medical virology2022

SARS-CoV-2 variant with mutations in N gene affecting detection by widely used PCR primers.

Pia Laine, Hanna Nihtilä, Ella Mustanoja, Annina Lyyski, Anne Ylinen, Jukka Hurme, Lars Paulin, Sakari Jokiranta, Petri Auvinen, Taru Meri

Open access · bronzeAbstract read
In one paragraph

Article in Journal of medical virology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.7field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. The Mutational Landscape of SARS-CoV-2.International journal of molecular sciences · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Pia LaineDNA Sequencing and Genomics, Helsinki Institute of Life Science HiLIFE, Institute of Biotechnology, University of Helsinki, Helsinki, Finland.
Hanna NihtiläVita Laboratory, Helsinki, Finland.
Ella MustanojaDNA Sequencing and Genomics, Helsinki Institute of Life Science HiLIFE, Institute of Biotechnology, University of Helsinki, Helsinki, Finland.
Annina LyyskiDNA Sequencing and Genomics, Helsinki Institute of Life Science HiLIFE, Institute of Biotechnology, University of Helsinki, Helsinki, Finland.
Anne YlinenDNA Sequencing and Genomics, Helsinki Institute of Life Science HiLIFE, Institute of Biotechnology, University of Helsinki, Helsinki, Finland.
Jukka HurmeVita Laboratory, Helsinki, Finland.
Lars PaulinDNA Sequencing and Genomics, Helsinki Institute of Life Science HiLIFE, Institute of Biotechnology, University of Helsinki, Helsinki, Finland.
Sakari JokirantaVita Laboratory, Helsinki, Finland.
Petri AuvinenDNA Sequencing and Genomics, Helsinki Institute of Life Science HiLIFE, Institute of Biotechnology, University of Helsinki, Helsinki, Finland.
Taru MeriVita Laboratory, Helsinki, Finland.
University of Helsinki · FIInstituto Vita · BRFimlab (Finland) · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While most of the spontaneous mutations in the viral genome have no functional, diagnostic, or clinical consequences, some have. In February 2021, we noticed in Southern Finland coronavirus disease 2019 cases where two commercial polymerase chain reaction (PCR) analyses failed to recognize the used N gene target but recognized the other target gene of severe acute respiratory syndrome coronavirus 2. Complete viral genome sequence analysis of the strains revealed several mutations that were not found at that time in public databases. A short 3 bp deletion and three subsequent single nucleotide polymorphisms in the N gene were found exactly at the site where an early published and widely used N gene-based PCR primer is located, explaining the negative results in the N gene PCR. Later the variant strain was identified as a member of the B.1.1.318 Pango lineage that had first been found from Nigerian samples collected in January 2021. This strain shares with the Beta variant the S gene E484K mutation linked to impaired vaccine protection, but differs from this variant in several other ways, for example by deletions in the N gene region. Mutations in the N gene causing diagnostic resistance and on the other hand E484K mutation in the causing altered infectivity warrants careful inspection on virus variants that might get underdiagnosed.

Indexed as

COVID-19SARS-CoV-2HumansMutationPolymerase Chain ReactiondiagnosisN genePCRSARS CoV-2sequencing

Identifiers

PMID34698407
PMCPMC8661661
OpenAlexW3209754846

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.